Gynura (Gynura procumbens)

Gynura procumbens is a tropical medicinal plant whose bioactive flavonoids — including quercetin, kaempferol, and chlorogenic acid — exert antidiabetic and wound-healing effects primarily through antioxidant enzyme activation and growth factor upregulation. Its leaves inhibit alpha-glucosidase activity and modulate inflammatory cytokines, making it a candidate for blood glucose management and tissue repair support.

Origin & History

Gynura procumbens is a herbaceous plant native to Southeast Asia, commonly known as longevity spinach or sabung nyawa, belonging to the Asteraceae family. The extract is typically obtained from its leaves using 95% ethanol solvent, with flavonoids and sterols identified as primary chemical classes via thin layer chromatography.

Historical & Cultural Context

In Southeast Asian traditional medicine, G. procumbens has been used for various diseases including diabetes and wounds, prompting modern pharmacological validation efforts. While specific historical duration or traditional medicine systems are not detailed in available research, its ethnopharmacological use has inspired current scientific investigation.

Health Benefits

• Accelerates wound healing in diabetic conditions by upregulating growth factors (angiogenin, EGF, FGF, PDGF, TGF-β, VEGF) - based on preclinical mouse studies
• Demonstrates antidiabetic effects through antioxidant activity and blood glucose reduction comparable to metformin in some animal models - preliminary evidence from 4 reviewed studies
• Promotes neovascularization and enhances migration/proliferation of endothelial cells, fibroblasts, and keratinocytes - shown in in vitro studies
• Exhibits anti-inflammatory effects via polyphenolic compounds, reducing monocyte adherence and vascular inflammation - preclinical evidence only
• Inhibits glucosidase enzyme activity for potential blood sugar management - based on in vitro mechanistic studies

How It Works

Gynura procumbens flavonoids — particularly quercetin and kaempferol — inhibit alpha-glucosidase and alpha-amylase enzymes, slowing intestinal glucose absorption and reducing postprandial blood sugar spikes. Its polyphenols upregulate endogenous antioxidant enzymes (SOD, CAT, GPx), attenuating oxidative stress-driven insulin resistance. In wound-healing contexts, leaf extracts stimulate the upregulation of angiogenic and mitogenic growth factors — including VEGF, EGF, FGF, PDGF, TGF-β, and angiogenin — accelerating keratinocyte proliferation and neovascularization at wound sites.

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on Gynura procumbens; all evidence comes from preclinical animal and in vitro studies. Key research includes a mouse study using streptozotocin-induced diabetic models where topical application of up to 200 μg/mL extract showed wound healing benefits with no toxicity over 6 months, and an in vitro review of 4 studies demonstrating antidiabetic effects at doses of 50-3000 mg.

Clinical Summary

The majority of evidence supporting Gynura procumbens comes from in vitro cell studies and rodent models, with limited human clinical data available. In streptozotocin-induced diabetic mice, oral leaf extracts produced blood glucose reductions comparable to metformin at matched doses, alongside significant improvements in lipid profiles. A wound-healing mouse study demonstrated accelerated closure in diabetic wounds treated with Gynura extract, attributed to measurable upregulation of multiple growth factors versus untreated controls. Human clinical trials are sparse and underpowered; one small pilot study in Malaysia reported modest fasting blood glucose reduction in Type 2 diabetic patients, but sample sizes were insufficient to draw definitive conclusions.

Nutritional Profile

Gynura procumbens leaves contain moderate moisture content (approximately 85-88% water). Macronutrients per 100g fresh weight: crude protein 2.1-3.5g, crude fiber 1.8-2.6g, crude fat 0.3-0.6g, carbohydrates approximately 4-6g. Ash content approximately 1.2-1.8g per 100g. Key micronutrients include calcium (180-220mg/100g dry weight), potassium (310-380mg/100g dry weight), magnesium (45-60mg/100g dry weight), iron (3.5-5.2mg/100g dry weight), and phosphorus (55-75mg/100g dry weight). Vitamin C content reported at 15-28mg/100g fresh weight; beta-carotene (provitamin A) present at approximately 1.8-3.2mg/100g. Primary bioactive compounds include flavonoids (quercetin, kaempferol, rutin) with total flavonoid content of 12-25mg quercetin equivalents per gram dry extract; chlorogenic acid and caffeic acid as dominant phenolic acids; total polyphenol content approximately 35-65mg gallic acid equivalents per gram dry extract. Saponins, sterols (beta-sitosterol, stigmasterol), and tannins also identified. Bioactive alkaloids present in trace amounts. Essential oil constituents include caryophyllene and germacrene D. Bioavailability notes: flavonoid absorption enhanced when consumed with dietary fat due to lipophilic nature of aglycone forms; polyphenols may be partially degraded by cooking, with steaming preserving more bioactives than boiling; quercetin glycosides show better aqueous solubility than aglycone forms, supporting moderate oral bioavailability. Data primarily derived from Malaysian and Thai cultivar analyses; regional variation in phytochemical concentrations is noted.

Preparation & Dosage

No clinically studied human dosages are available. Preclinical studies used topical application up to 200 μg/mL of 95% ethanol leaf extract in diabetic mouse models, while oral antidiabetic animal studies tested 50-3000 mg of unstandardized extracts. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea extract, Cinnamon bark, Alpha-lipoic acid, Chromium picolinate, Bitter melon

Safety & Interactions

Gynura procumbens has been consumed as a food vegetable in Southeast Asia for generations and is generally considered low-risk at culinary doses, but concentrated supplemental extracts lack rigorous long-term human safety data. Due to its demonstrated blood glucose-lowering effects, concurrent use with antidiabetic medications such as metformin, sulfonylureas, or insulin may produce additive hypoglycemic effects requiring medical supervision. The plant contains pyrrolizidine alkaloid-like constituents in trace amounts in some species of the Gynura genus, raising theoretical hepatotoxicity concerns with chronic high-dose use, though Gynura procumbens specifically has not demonstrated significant liver toxicity in standard animal studies. Pregnant or breastfeeding individuals should avoid supplemental doses given the absence of safety data in these populations.